カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の静脈内注射免疫グロブリン市場2022年：1g/20ml、 1.25g/25ml、 2.5g/50ml、 5g/100ml、 10g/200ml

◆英語タイトル：Global Intravenous Injection Immunoglobulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8867 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：99 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

静脈内注射免疫グロブリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の静脈内注射免疫グロブリンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

静脈内注射免疫グロブリン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・1g/20ml、 1.25g/25ml、 2.5g/50ml、 5g/100ml、 10g/200ml

用途別セグメントは次のように区分されます。
・病院、クリニック、その他

世界の静脈内注射免疫グロブリン市場の主要な市場プレーヤーは以下のとおりです。
・Boya-Bio、Beijing Tiantan Biological Products、Hualan Bio、Guangdong Shuagnlin Bio-pharmacy、Weiguang Biological、Sinopharm、Shanghai RAAS、CTBB、Nanyue Biopharming

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、静脈内注射免疫グロブリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な静脈内注射免疫グロブリンメーカーの企業概要、2019年～2022年までの静脈内注射免疫グロブリンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な静脈内注射免疫グロブリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別静脈内注射免疫グロブリンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの静脈内注射免疫グロブリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での静脈内注射免疫グロブリン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および静脈内注射免疫グロブリンの産業チェーンを掲載しています。
・第13、14、15章では、静脈内注射免疫グロブリンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Boya-Bio、Beijing Tiantan Biological Products、Hualan Bio、Guangdong Shuagnlin Bio-pharmacy、Weiguang Biological、Sinopharm、Shanghai RAAS、CTBB、Nanyue Biopharming
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：1g/20ml、 1.25g/25ml、 2.5g/50ml、 5g/100ml、 10g/200ml
・用途別分析2017年-2028年：病院、クリニック、その他
・静脈内注射免疫グロブリンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・静脈内注射免疫グロブリンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・静脈内注射免疫グロブリンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・静脈内注射免疫グロブリンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・静脈内注射免疫グロブリンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Intravenous Injection Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intravenous Injection Immunoglobulin market size is estimated to be worth US$ 10610 million in 2021 and is forecast to a readjusted size of USD 15460 million by 2028 with a CAGR of 5.5% during review period. Hospital accounting for % of the Intravenous Injection Immunoglobulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 1g/20ml segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Intravenous Injection Immunoglobulin include Boya-Bio, Beijing Tiantan Biological Products, Hualan Bio, Guangdong Shuagnlin Bio-pharmacy, and Weiguang Biological, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intravenous Injection Immunoglobulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
1g/20ml
1.25g/25ml
2.5g/50ml
5g/100ml
10g/200ml
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Intravenous Injection Immunoglobulin market are listed below:
Boya-Bio
Beijing Tiantan Biological Products
Hualan Bio
Guangdong Shuagnlin Bio-pharmacy
Weiguang Biological
Sinopharm
Shanghai RAAS
CTBB
Nanyue Biopharming
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Injection Immunoglobulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravenous Injection Immunoglobulin, with price, sales, revenue and global market share of Intravenous Injection Immunoglobulin from 2019 to 2022.
Chapter 3, the Intravenous Injection Immunoglobulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Injection Immunoglobulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intravenous Injection Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intravenous Injection Immunoglobulin.
Chapter 13, 14, and 15, to describe Intravenous Injection Immunoglobulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Intravenous Injection Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intravenous Injection Immunoglobulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 1g/20ml
1.2.3 1.25g/25ml
1.2.4 2.5g/50ml
1.2.5 5g/100ml
1.2.6 10g/200ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Intravenous Injection Immunoglobulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Intravenous Injection Immunoglobulin Market Size & Forecast
1.4.1 Global Intravenous Injection Immunoglobulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Intravenous Injection Immunoglobulin Sales in Volume (2017-2028)
1.4.3 Global Intravenous Injection Immunoglobulin Price (2017-2028)
1.5 Global Intravenous Injection Immunoglobulin Production Capacity Analysis
1.5.1 Global Intravenous Injection Immunoglobulin Total Production Capacity (2017-2028)
1.5.2 Global Intravenous Injection Immunoglobulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intravenous Injection Immunoglobulin Market Drivers
1.6.2 Intravenous Injection Immunoglobulin Market Restraints
1.6.3 Intravenous Injection Immunoglobulin Trends Analysis
2 Manufacturers Profiles
2.1 Boya-Bio
2.1.1 Boya-Bio Details
2.1.2 Boya-Bio Major Business
2.1.3 Boya-Bio Intravenous Injection Immunoglobulin Product and Services
2.1.4 Boya-Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Beijing Tiantan Biological Products
2.2.1 Beijing Tiantan Biological Products Details
2.2.2 Beijing Tiantan Biological Products Major Business
2.2.3 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product and Services
2.2.4 Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hualan Bio
2.3.1 Hualan Bio Details
2.3.2 Hualan Bio Major Business
2.3.3 Hualan Bio Intravenous Injection Immunoglobulin Product and Services
2.3.4 Hualan Bio Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Guangdong Shuagnlin Bio-pharmacy
2.4.1 Guangdong Shuagnlin Bio-pharmacy Details
2.4.2 Guangdong Shuagnlin Bio-pharmacy Major Business
2.4.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product and Services
2.4.4 Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Weiguang Biological
2.5.1 Weiguang Biological Details
2.5.2 Weiguang Biological Major Business
2.5.3 Weiguang Biological Intravenous Injection Immunoglobulin Product and Services
2.5.4 Weiguang Biological Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sinopharm
2.6.1 Sinopharm Details
2.6.2 Sinopharm Major Business
2.6.3 Sinopharm Intravenous Injection Immunoglobulin Product and Services
2.6.4 Sinopharm Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business
2.7.3 Shanghai RAAS Intravenous Injection Immunoglobulin Product and Services
2.7.4 Shanghai RAAS Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CTBB
2.8.1 CTBB Details
2.8.2 CTBB Major Business
2.8.3 CTBB Intravenous Injection Immunoglobulin Product and Services
2.8.4 CTBB Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Nanyue Biopharming
2.9.1 Nanyue Biopharming Details
2.9.2 Nanyue Biopharming Major Business
2.9.3 Nanyue Biopharming Intravenous Injection Immunoglobulin Product and Services
2.9.4 Nanyue Biopharming Intravenous Injection Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Intravenous Injection Immunoglobulin Breakdown Data by Manufacturer
3.1 Global Intravenous Injection Immunoglobulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Intravenous Injection Immunoglobulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Intravenous Injection Immunoglobulin
3.4 Market Concentration Rate
3.4.1 Top 3 Intravenous Injection Immunoglobulin Manufacturer Market Share in 2021
3.4.2 Top 6 Intravenous Injection Immunoglobulin Manufacturer Market Share in 2021
3.5 Global Intravenous Injection Immunoglobulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Intravenous Injection Immunoglobulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intravenous Injection Immunoglobulin Market Size by Region
4.1.1 Global Intravenous Injection Immunoglobulin Sales in Volume by Region (2017-2028)
4.1.2 Global Intravenous Injection Immunoglobulin Revenue by Region (2017-2028)
4.2 North America Intravenous Injection Immunoglobulin Revenue (2017-2028)
4.3 Europe Intravenous Injection Immunoglobulin Revenue (2017-2028)
4.4 Asia-Pacific Intravenous Injection Immunoglobulin Revenue (2017-2028)
4.5 South America Intravenous Injection Immunoglobulin Revenue (2017-2028)
4.6 Middle East and Africa Intravenous Injection Immunoglobulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Intravenous Injection Immunoglobulin Sales in Volume by Type (2017-2028)
5.2 Global Intravenous Injection Immunoglobulin Revenue by Type (2017-2028)
5.3 Global Intravenous Injection Immunoglobulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Intravenous Injection Immunoglobulin Sales in Volume by Application (2017-2028)
6.2 Global Intravenous Injection Immunoglobulin Revenue by Application (2017-2028)
6.3 Global Intravenous Injection Immunoglobulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
7.2 North America Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
7.3 North America Intravenous Injection Immunoglobulin Market Size by Country
7.3.1 North America Intravenous Injection Immunoglobulin Sales in Volume by Country (2017-2028)
7.3.2 North America Intravenous Injection Immunoglobulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
8.2 Europe Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
8.3 Europe Intravenous Injection Immunoglobulin Market Size by Country
8.3.1 Europe Intravenous Injection Immunoglobulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Intravenous Injection Immunoglobulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
9.2 Asia-Pacific Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
9.3 Asia-Pacific Intravenous Injection Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Intravenous Injection Immunoglobulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Intravenous Injection Immunoglobulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
10.2 South America Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
10.3 South America Intravenous Injection Immunoglobulin Market Size by Country
10.3.1 South America Intravenous Injection Immunoglobulin Sales in Volume by Country (2017-2028)
10.3.2 South America Intravenous Injection Immunoglobulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intravenous Injection Immunoglobulin Sales by Type (2017-2028)
11.2 Middle East & Africa Intravenous Injection Immunoglobulin Sales by Application (2017-2028)
11.3 Middle East & Africa Intravenous Injection Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Intravenous Injection Immunoglobulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Intravenous Injection Immunoglobulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Intravenous Injection Immunoglobulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Intravenous Injection Immunoglobulin
12.3 Intravenous Injection Immunoglobulin Production Process
12.4 Intravenous Injection Immunoglobulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Intravenous Injection Immunoglobulin Typical Distributors
13.3 Intravenous Injection Immunoglobulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Intravenous Injection Immunoglobulin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Intravenous Injection Immunoglobulin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Boya-Bio Basic Information, Manufacturing Base and Competitors
Table 4. Boya-Bio Major Business
Table 5. Boya-Bio Intravenous Injection Immunoglobulin Product and Services
Table 6. Boya-Bio Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Beijing Tiantan Biological Products Basic Information, Manufacturing Base and Competitors
Table 8. Beijing Tiantan Biological Products Major Business
Table 9. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Product and Services
Table 10. Beijing Tiantan Biological Products Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 12. Hualan Bio Major Business
Table 13. Hualan Bio Intravenous Injection Immunoglobulin Product and Services
Table 14. Hualan Bio Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Guangdong Shuagnlin Bio-pharmacy Basic Information, Manufacturing Base and Competitors
Table 16. Guangdong Shuagnlin Bio-pharmacy Major Business
Table 17. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Product and Services
Table 18. Guangdong Shuagnlin Bio-pharmacy Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Weiguang Biological Basic Information, Manufacturing Base and Competitors
Table 20. Weiguang Biological Major Business
Table 21. Weiguang Biological Intravenous Injection Immunoglobulin Product and Services
Table 22. Weiguang Biological Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sinopharm Basic Information, Manufacturing Base and Competitors
Table 24. Sinopharm Major Business
Table 25. Sinopharm Intravenous Injection Immunoglobulin Product and Services
Table 26. Sinopharm Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 28. Shanghai RAAS Major Business
Table 29. Shanghai RAAS Intravenous Injection Immunoglobulin Product and Services
Table 30. Shanghai RAAS Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. CTBB Basic Information, Manufacturing Base and Competitors
Table 32. CTBB Major Business
Table 33. CTBB Intravenous Injection Immunoglobulin Product and Services
Table 34. CTBB Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Nanyue Biopharming Basic Information, Manufacturing Base and Competitors
Table 36. Nanyue Biopharming Major Business
Table 37. Nanyue Biopharming Intravenous Injection Immunoglobulin Product and Services
Table 38. Nanyue Biopharming Intravenous Injection Immunoglobulin Sales (L), Price (US$/ml), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Intravenous Injection Immunoglobulin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (L)
Table 40. Global Intravenous Injection Immunoglobulin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Intravenous Injection Immunoglobulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Intravenous Injection Immunoglobulin Production Capacity by Company, (L): 2020 VS 2021
Table 43. Head Office and Intravenous Injection Immunoglobulin Production Site of Key Manufacturer
Table 44. Intravenous Injection Immunoglobulin New Entrant and Capacity Expansion Plans
Table 45. Intravenous Injection Immunoglobulin Mergers & Acquisitions in the Past Five Years
Table 46. Global Intravenous Injection Immunoglobulin Sales by Region (2017-2022) & (L)
Table 47. Global Intravenous Injection Immunoglobulin Sales by Region (2023-2028) & (L)
Table 48. Global Intravenous Injection Immunoglobulin Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Intravenous Injection Immunoglobulin Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
Table 51. Global Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
Table 52. Global Intravenous Injection Immunoglobulin Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Intravenous Injection Immunoglobulin Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Intravenous Injection Immunoglobulin Price by Type (2017-2022) & (US$/ml)
Table 55. Global Intravenous Injection Immunoglobulin Price by Type (2023-2028) & (US$/ml)
Table 56. Global Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
Table 57. Global Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
Table 58. Global Intravenous Injection Immunoglobulin Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Intravenous Injection Immunoglobulin Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Intravenous Injection Immunoglobulin Price by Application (2017-2022) & (US$/ml)
Table 61. Global Intravenous Injection Immunoglobulin Price by Application (2023-2028) & (US$/ml)
Table 62. North America Intravenous Injection Immunoglobulin Sales by Country (2017-2022) & (L)
Table 63. North America Intravenous Injection Immunoglobulin Sales by Country (2023-2028) & (L)
Table 64. North America Intravenous Injection Immunoglobulin Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Intravenous Injection Immunoglobulin Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
Table 67. North America Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
Table 68. North America Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
Table 69. North America Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
Table 70. Europe Intravenous Injection Immunoglobulin Sales by Country (2017-2022) & (L)
Table 71. Europe Intravenous Injection Immunoglobulin Sales by Country (2023-2028) & (L)
Table 72. Europe Intravenous Injection Immunoglobulin Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Intravenous Injection Immunoglobulin Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
Table 75. Europe Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
Table 76. Europe Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
Table 77. Europe Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
Table 78. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Region (2017-2022) & (L)
Table 79. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Region (2023-2028) & (L)
Table 80. Asia-Pacific Intravenous Injection Immunoglobulin Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Intravenous Injection Immunoglobulin Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
Table 83. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
Table 84. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
Table 85. Asia-Pacific Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
Table 86. South America Intravenous Injection Immunoglobulin Sales by Country (2017-2022) & (L)
Table 87. South America Intravenous Injection Immunoglobulin Sales by Country (2023-2028) & (L)
Table 88. South America Intravenous Injection Immunoglobulin Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Intravenous Injection Immunoglobulin Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
Table 91. South America Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
Table 92. South America Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
Table 93. South America Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
Table 94. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Region (2017-2022) & (L)
Table 95. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Region (2023-2028) & (L)
Table 96. Middle East & Africa Intravenous Injection Immunoglobulin Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Intravenous Injection Immunoglobulin Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Type (2017-2022) & (L)
Table 99. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Type (2023-2028) & (L)
Table 100. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Application (2017-2022) & (L)
Table 101. Middle East & Africa Intravenous Injection Immunoglobulin Sales by Application (2023-2028) & (L)
Table 102. Intravenous Injection Immunoglobulin Raw Material
Table 103. Key Manufacturers of Intravenous Injection Immunoglobulin Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Intravenous Injection Immunoglobulin Typical Distributors
Table 107. Intravenous Injection Immunoglobulin Typical Customers
List of Figures
Figure 1. Intravenous Injection Immunoglobulin Picture
Figure 2. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type in 2021
Figure 3. 1g/20ml
Figure 4. 1.25g/25ml
Figure 5. 2.5g/50ml
Figure 6. 5g/100ml
Figure 7. 10g/200ml
Figure 8. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application in 2021
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Intravenous Injection Immunoglobulin Revenue, (USD Million) & (L): 2017 & 2021 & 2028
Figure 13. Global Intravenous Injection Immunoglobulin Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Intravenous Injection Immunoglobulin Sales (2017-2028) & (L)
Figure 15. Global Intravenous Injection Immunoglobulin Price (2017-2028) & (US$/ml)
Figure 16. Global Intravenous Injection Immunoglobulin Production Capacity (2017-2028) & (L)
Figure 17. Global Intravenous Injection Immunoglobulin Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Intravenous Injection Immunoglobulin Market Drivers
Figure 19. Intravenous Injection Immunoglobulin Market Restraints
Figure 20. Intravenous Injection Immunoglobulin Market Trends
Figure 21. Global Intravenous Injection Immunoglobulin Sales Market Share by Manufacturer in 2021
Figure 22. Global Intravenous Injection Immunoglobulin Revenue Market Share by Manufacturer in 2021
Figure 23. Intravenous Injection Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Intravenous Injection Immunoglobulin Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Intravenous Injection Immunoglobulin Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Intravenous Injection Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 27. Global Intravenous Injection Immunoglobulin Revenue Market Share by Region (2017-2028)
Figure 28. North America Intravenous Injection Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 29. Europe Intravenous Injection Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Intravenous Injection Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 31. South America Intravenous Injection Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Intravenous Injection Immunoglobulin Revenue (2017-2028) & (USD Million)
Figure 33. Global Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 34. Global Intravenous Injection Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 35. Global Intravenous Injection Immunoglobulin Price by Type (2017-2028) & (US$/ml)
Figure 36. Global Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 37. Global Intravenous Injection Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 38. Global Intravenous Injection Immunoglobulin Price by Application (2017-2028) & (US$/ml)
Figure 39. North America Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 40. North America Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 41. North America Intravenous Injection Immunoglobulin Sales Market Share by Country (2017-2028)
Figure 42. North America Intravenous Injection Immunoglobulin Revenue Market Share by Country (2017-2028)
Figure 43. United States Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 47. Europe Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 48. Europe Intravenous Injection Immunoglobulin Sales Market Share by Country (2017-2028)
Figure 49. Europe Intravenous Injection Immunoglobulin Revenue Market Share by Country (2017-2028)
Figure 50. Germany Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Intravenous Injection Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Intravenous Injection Immunoglobulin Revenue Market Share by Region (2017-2028)
Figure 59. China Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 66. South America Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 67. South America Intravenous Injection Immunoglobulin Sales Market Share by Country (2017-2028)
Figure 68. South America Intravenous Injection Immunoglobulin Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Intravenous Injection Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Intravenous Injection Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Intravenous Injection Immunoglobulin Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Intravenous Injection Immunoglobulin Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Intravenous Injection Immunoglobulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Intravenous Injection Immunoglobulin in 2021
Figure 80. Manufacturing Process Analysis of Intravenous Injection Immunoglobulin
Figure 81. Intravenous Injection Immunoglobulin Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の静脈内注射免疫グロブリン市場2022年：1g/20ml、 1.25g/25ml、 2.5g/50ml、 5g/100ml、 10g/200ml(Global Intravenous Injection Immunoglobulin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の静脈内注射免疫グロブリン市場2022年：1g/20ml、 1.25g/25ml、 2.5g/50ml、 5g/100ml、 10g/200ml

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp